Windlas Biotech Limited - Company Profile

Q: Where is Windlas Biotech Limited headquartered?

Windlas Biotech Limited is headquartered at 401 Mohabewala Industrial Area, Dehradun, Uttarakhand, 248110.

Q: Who are the current directors of Windlas Biotech Limited?

The current directors of Windlas Biotech Limited are Hitesh Windlass, Pawan Kumar Sharma, Manoj Kumar Windlass, Prachi Jain Windlass, Ananta Narayan Panda, Gaurav Gulati, Srinivasan Venkataraman, Vivek Dhariwal, Ashok Kumar Windlass, Komal Gupta.

It is a pharma public limited company based in Dehradun, Uttarakhand, India, established in 2001.

2001 Dehradun, Uttarakhand, India Active

Last Updated: February 18, 2026

Access Report

About Windlas Biotech Limited

Windlas Biotech Limited, a active public limited company, was established on 19 February 2001 in Dehradun, Uttarakhand, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L74899UR2001PLC033407. Registered under ROC Roc Uttarakhand. it is listed on BSE: 543329 and NSE: WINDLAS. It has an authorized capital of ₹77.50 Cr and a paid-up capital of ₹10.54 Cr.

Formerly known as Windlas Biotech Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹644.42 Cr and a net worth of ₹450.29 Cr. Employing 1,153 professional, Its leadership includes Hitesh Windlass (Managing Director), Pawan Kumar Sharma (Whole-Time Director), Manoj Kumar Windlass (Person Incharge). Past directors included Hitesh Windlass, Pawan Kumar Sharma, Manish Kumar. It holds ₹73.30 Cr open charges and ₹183.40 Cr settled loans. Its latest AGM occurred on 28 July 2025, with the balance sheet filed on 31 March 2025. It is based at 40/1 Mohabewala Industrial Area, Dehradun, Uttarakhand, 248110.

Company Details

CIN/LLPIN
L74899UR2001PLC033407
Registration Number
033407
Incorporation Date
19 February 2001
Authorized Capital
₹77.50 Cr
Paid-Up Capital
₹10.54 Cr
ROC Code
Roc Uttarakhand
Listing Status
Listed (BSE: 543329, NSE: WINDLAS)
Company Status
Active

Key Metrics

Authorised Capital ₹ 77.50 Cr as on 18-02-2026
Paid Up Capital ₹ 10.54 Cr as on 18-02-2026
Company Age 25 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 73.30 Cr as on 18-02-2026
Satisfied Charges ₹ 183.40 Cr as on 18-02-2026
Revenue Growth **** 20.65% (FY 2025)
Profit Growth **** 4.31% (FY 2025)
Ebitda **** 20.50% (FY 2025)
Net Worth 12.32% (FY 2025)
Total Assets **** 21.45% (FY 2025)

Comprehensive Company Insights

Explore comprehensive insights into Windlas Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Windlas Biotech Limited?

Current Directors

Name	Designation	Appointment Date	Status
Hitesh Windlass	Managing Director	21 Jan 2008	Current
Pawan Kumar Sharma	Whole-Time Director	11 Jun 2019	Current
Manoj Kumar Windlass	Person Incharge	17 Jul 2015	Current
Prachi Jain Windlass	Director	03 May 2021	Current
Gaurav Gulati	Director	06 May 2021	Current
Srinivasan Venkataraman	Director	06 May 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Apr 2020	Past
Pramod Abcsdd	Additional Director	25 Sep 2019	Past
Pramod Abcsdd	Company Secretary	23 Feb 2008	Past
Pramod Abcsdd	Director	21 Apr 2021	Past
Pramod Abcsdd	Director	30 Apr 2020	Past
Pramod Abcsdd	Director	15 Sep 2010	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Windlas Biotech.

Windlas Biotech Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 20.65% increase. The company also saw a slight improvement in profitability, with a 4.31% increase in profit. The company's net worth Soared by an impressive increase of 12.32%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

20.65%

*******

Revenue from Operations

*******

20.43%

*******

Total Assets

*******

21.45%

*******

Profit or Loss

*******

4.31%

*******

Net Worth

*******

12.32%

*******

EBITDA

*******

20.50%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Windlas Biotech?

In 2024, Windlas Biotech had a promoter holding of 62.82% and a public holding of 37.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹733,000,000.00

Satisfied Charges

₹1,834,000,000.00

Charges Breakdown by Lending Institutions

The Hongkong And Shanghai Banking Corporation Limited : 40.00 Cr
Hdfc Bank Limited : 23.30 Cr
Others : 10.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
27 May 2022	The Hongkong And Shanghai Banking Corporation Limited	₹40.00 Cr	Open
04 Feb 2015	Others	₹10.00 Cr	Open
28 Apr 2010	Hdfc Bank Limited	₹23.30 Cr	Open
16 Apr 2021	Others	₹20.00 Cr	Satisfied
16 Mar 2021	Others	₹20.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Windlas Biotech?

Windlas Biotech has a workforce of 1153 employees as of Feb 18, 2026. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Windlas Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Windlas Biotech's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Windlas Biotech

Recent Activity within the Organization

Annual General Meeting

Progress on Windlas Biotech Limited last Annual general meeting of members was held on 28 Jul 2025 as per latest MCA records. was documented.
28 Jul 2025
Balance Sheet

The activity Windlas Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand. was completed.
31 Mar 2025
Charges

Progress on A charge registered on 13 Jul 2020 via Charge ID 100360093 with Sidbi was fully satisfied on 20 Mar 2025. was documented.
20 Mar 2025
Charges

Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 40.00 Cr registered on 27 May 2022 with Charge ID 100575416 was modified on 17 Mar 2025. was documented.
17 Mar 2025
Charges

The activity A charge with Hdfc Bank Limited of Rs. 23.30 Cr registered on 28 Apr 2010 with Charge ID 10223457 was modified on 08 Jan 2025. was completed.
08 Jan 2025
Charges

Progress on A charge with Others of Rs. 10.00 Cr registered on 04 Feb 2015 with Charge ID 10547318 was modified on 30 Apr 2024. was documented.
30 Apr 2024

Explore recent activity and updates - View Recent Activity